0001493152-23-042626.txt : 20240104 0001493152-23-042626.hdr.sgml : 20240104 20231124120634 ACCESSION NUMBER: 0001493152-23-042626 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tharimmune, Inc. CENTRAL INDEX KEY: 0001861657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 842642541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1200 ROUTE 22 EAST CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 302-743-2995 MAIL ADDRESS: STREET 1: 245 MAIN STREET STREET 2: SUITE 204 CITY: CHESTER STATE: NJ ZIP: 07930 FORMER COMPANY: FORMER CONFORMED NAME: Tharimmune, Inc DATE OF NAME CHANGE: 20230925 FORMER COMPANY: FORMER CONFORMED NAME: Hillstream BioPharma Inc. DATE OF NAME CHANGE: 20210511 CORRESP 1 filename1.htm

Tharimmune, Inc.

1200 Route 22 East, Suite 2000

Bridgewater, NJ 08807

November 24, 2023

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Daniel Crawford

	Re:	Tharimmune, Inc.
		Registration Statement on Form S-1
		File No. 333-275350

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Tharimmune, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Tuesday, November 28, 2023, or as soon thereafter as possible.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

	THARIMMUNE, INC.

	By:	/s/ Randy Milby
	Name:	Randy Milby
	Title:	Chief Executive Officer